Prova en annan sökning
13657
ORD
Namn | Ålder | Sedan | Titel |
---|---|---|---|
Namio Matsumoto | 80 | 2007 | Chairman |
Kiyoo Matsumoto | 50 | 2009 | CEO, President & Representative Director |
Akio Ishibashi | 59 | 2017 | MD, Head of Group Management Planning & Director |
Hisao Honta | 63 | - | Full-Time Auditor |
Keiji Kimura | 76 | - | Independent Outside Director |
Akira Torii | 74 | - | Independent Audit & Supervisory Board Member |
Makoto Tanima | 52 | - | Outside Independent Director |
Takashi Matsumoto | 48 | 2013 | Senior MD, Head of Group Sales Planning & Representative Director |
Shoichi Watanabe | 61 | - | Independent Audit & Supervisory Board Member |
Junko Kawai | 49 | - | Independent Outside Director |
Noriko Koike | 61 | - | Independent Audit & Supervisory Board Member |
Takashi Matsuda | 51 | - | Deputy Head of Group Sales Planning & Director |
Isao Matsushita | 76 | 2016 | Independent External Director |
Tomoko Okiyama | 69 | 2020 | Independent Outside Director |
Hiroo Omura | 77 | 2018 | Independent Outside Director |
Shingo Obe | 61 | 2017 | MD, Head of Group Management & Director |
Tsuyoshi Yamamoto | 57 | 2021 | Head of Group Business Planning & Director |
Atsushi Tsukamoto | 61 | 2021 | VP & Representative Director |
Ryoichi Watanabe | 49 | - | Head of Group Management, incharge of external relations & Pharmacy-related legislation & Director |
Är du säker på att du vill blockera %USER_NAME%?
Genom att blockera kan du och %USER_NAME% inte se varandras inlägg på Investing.com.
%USER_NAME% lyckades läggas till i din Blockeringslista
Eftersom du precis avblockerat denna person måste du vänta 48 timmar för att kunna förnya blockeringen.
Jag anser att denna kommentar är:
Tack!
Rapporten har skickats till våra moderatorer för granskning